Try our beta test site
903 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Recruiting Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Patient Reported Outcomes
9 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
10 Not yet recruiting Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Vinblastine Sulfate;   Radiation: three dimensional conformal radiotherapy
11 Not yet recruiting A Study of AK-01 in Solid Tumors
Conditions: Solid Tumor;   Neoplasms;   Neoplasm Metastasis;   Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: AK-01
12 Not yet recruiting A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)
Conditions: Advanced or Metastatic Solid Tumors;   Advanced or Metastatic Colorectal Cancer (CRC);   Pancreatic Ductal Adenocarcinoma (PDAC);   Non-Small Cell Lung Cancer (NSCLC; Squamous or Nonsquamous);   Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Protein 1 (PD-1) Inhibitor;   Advanced or Metastatic Solid Tumor That Progressed on Previous Therapy With a Programmed Cell Death Ligand 1 (PD-L1) Inhibitor
Interventions: Drug: Epacadostat;   Drug: Nivolumab;   Drug: Pembrolizumab;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5-Fluorouracil;   Drug: Gemcitabine;   Drug: nab-Paclitaxel;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed;   Drug: Cyclophosphamide
13 Not yet recruiting A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: SHR-1210;   Drug: Apatinib
14 Not yet recruiting Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer:Multicenter Controlled Study.(RadimiR-01)
Condition: Advanced Nsclc
Intervention: Radiation: radiotherapy
15 Not yet recruiting PDR001 in Combination With Platinum-doublet Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients
Condition: Non-small Cell Lung Cancer
Interventions: Drug: PDR001;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel
16 Recruiting A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
Condition: Non-Small Cell Lung Cancer
Intervention: Device: Video-Assisted Thoracoscopic Lobectomy with powered vascular stapler
17 Not yet recruiting Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Changes in Radical Radiotherapy of Locally Advanced NSCLC
Condition: Non Small Cell Lung Cancer Stage III
Intervention: Radiation: Radiation
18 Recruiting Preliminary Evaluation of Safety and Efficacy of Patients Who Participant in [14C] AC0010 Trail and Subsequent Receiving AC0010 Treatment
Condition: Carcinoma,Non-Small-Cell Lung
Intervention: Drug: AC0010
19 Not yet recruiting A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Lorlatinib;   Drug: Crizotinib
20 Recruiting A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Pemetrexed

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.